BioPharm International
CONTINUE TO SITE

OR WAIT 15 SECS

BioPharm International
Spotlight
COVID-19 UpdateAnalyticsDevelopmentDownstream ProcessingManufacturingOutsourcingQuality/GMPsUpstream Processing2020 Bio/Pharma Virtual Congress
Topic
View MoreAnalytical MethodsBioBusinessCell Culture/FermentationContinuous ProcessingDrug DeliveryFill/FinishFormulationProcess ChromatographyProcess Control/PATProcess DevelopmentQA/QCSeparation and PurificationSingle-Use SystemsSupply Chain
News
All NewsTop NewsBio/Pharma NewsIndustry NewsSupplier NewsEvents
Publications
All PublicationsBioPharm International
Resources
Biopharma InsightsSponsored eBooksSponsored PodcastsSponsored VideosWhitepapers
Webcasts
Subscribe
EnewsMagazine

  • About Us
  • Advertise
  • Editorial Information
  • Contact Us
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
  • MJHLS Brand Logo

© 2021 MJH Life Sciences and BioPharm International. All rights reserved.

Spotlight
  • COVID-19 Update
  • Analytics
  • Development
  • Downstream Processing
  • Manufacturing
  • Outsourcing
  • Quality/GMPs
  • Upstream Processing
  • 2020 Bio/Pharma Virtual Congress
TopicSee All >
  • Analytical Methods
  • BioBusiness
  • Cell Culture/Fermentation
  • Continuous Processing
  • Drug Delivery
  • Fill/Finish
  • Formulation
  • Process Chromatography
  • Process Control/PAT
  • Process Development
  • QA/QC
  • Separation and Purification
  • Single-Use Systems
  • Supply Chain
  • About Us
  • Advertise
  • Editorial Information
  • Contact Us
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
  • MJHLS Brand Logo

© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.

Viral Destruction: Sponsored Q&A by Microthermics

March 20, 2014

A range of industries?biotechnology, food and pharmaceuticals?must keep viral contamination out of their products. To do this effectively, a company needs a reliable, continuous process, and one that can be scaled to the company?s specific needs. To explore these topics, BioPharm International talked with John Miles, PhD, president and founder of MicroThermics Inc. This company specializes in small-scale solutions in high-temperature short-time (HTST) and ultra-high temperature (UHT) processes.

A range of industries—biotechnology, food and pharmaceuticals—must keep viral contamination out of their products. To do this effectively, a company needs a reliable, continuous process, and one that can be scaled to the company’s specific needs. To explore these topics, BioPharm International talked with John Miles, PhD, president and founder of MicroThermics Inc. This company specializes in small-scale solutions in high-temperature short-time (HTST) and ultra-high temperature (UHT) processes.